Call to Action: Pediatric MASLD Requires Immediate Attention to Curb Health Crisis
When discussing childhood obesity, we often think first about weight, body image, or future diabetes risk. Yet one of its most important and underestimated comorbidities is metabolic dysfunction-associated steatotic liver disease, now termed MASLD. This condition reflects fatty liver in the setting of metabolic abnormalities and has become a clinical expression of the systemic damage linked to excess adiposity. In pediatrics, its importance is growing because it is no longer a subspecialty rarity, but an increasingly common condition in children and adolescents with obesity. Medically, MASLD is not a benign incidental finding. It is associated with insulin resistance, dyslipidemia, hypertension, chronic low-grade inflammation, and progression to more severe liver disease. The Hepatology article emphasizes that pediatric MASLD is linked to major childhood comorbidities and a 40-fold higher risk of early mortality in young adulthood, and notes that it has become th...